Subsequently, this impairs IDH1-dependent reductive carboxylation, a tumor cell requirement limited to 3D growth, inducing a decrease in intramitochondrial NADPH, an increase in ROS, and finally mitochondrial supercomplexes’ assembly disruption, which ultimately impairs cell transformation and tumorigenesis. This evidence concerns the gene IDH1 and neoplasm.